USD 1.24
(2.48%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 14.03 Million USD | -62.91% |
2022 | 37.84 Million USD | 34.06% |
2021 | 28.22 Million USD | 996.58% |
2020 | 2.57 Million USD | 280.77% |
2019 | 676 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 8.51 Million USD | -22.0% |
2024 Q1 | 12.79 Million USD | -12.48% |
2023 FY | 14.03 Million USD | -62.91% |
2023 Q3 | 38.98 Million USD | -0.49% |
2023 Q2 | 39.17 Million USD | -0.47% |
2023 Q1 | 39.36 Million USD | 4.02% |
2023 Q4 | 14.03 Million USD | -64.0% |
2022 Q3 | 37.72 Million USD | 34.58% |
2022 Q2 | 28.02 Million USD | -0.23% |
2022 Q1 | 28.09 Million USD | -0.47% |
2022 FY | 37.84 Million USD | 34.06% |
2022 Q4 | 37.84 Million USD | 0.32% |
2021 Q4 | 28.22 Million USD | -0.4% |
2021 FY | 28.22 Million USD | 996.58% |
2021 Q3 | 28.33 Million USD | 1257.18% |
2021 Q2 | 2.08 Million USD | 0.0% |
2021 Q1 | - USD | -100.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | 2.57 Million USD | 280.77% |
2020 Q4 | 2.57 Million USD | 0.0% |
2019 FY | 676 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott Laboratories | 13.59 Billion USD | 99.897% |
Allurion Technologies Inc. | 2.3 Million USD | -508.63% |
Artivion, Inc. | 305.53 Million USD | 95.406% |
Avanos Medical, Inc. | 159.4 Million USD | 91.195% |
Butterfly Network, Inc. | 22.83 Million USD | 38.537% |
Butterfly Network, Inc. | 22.83 Million USD | 38.537% |
Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 98.82% |
Boston Scientific Corporation | 8.96 Billion USD | 99.843% |
CONMED Corporation | 971.48 Million USD | 98.555% |
Edwards Lifesciences Corporation | 670 Million USD | 97.905% |
Paragon 28, Inc. | 109.79 Million USD | 87.218% |
Glaukos Corporation | 383.73 Million USD | 96.343% |
Globus Medical, Inc. | 417.4 Million USD | 96.638% |
Inspire Medical Systems, Inc. | 24.84 Million USD | 43.512% |
Integer Holdings Corporation | 959.92 Million USD | 98.538% |
Medtronic plc | 23.87 Billion USD | 99.941% |
Myomo, Inc. | 115.16 Thousand USD | -12087.391% |
Nevro Corp. | 211.47 Million USD | 93.363% |
Owlet, Inc. | 22 Thousand USD | -63695.455% |
Penumbra, Inc. | 220.9 Million USD | 93.647% |
Vicarious Surgical Inc. | 13.78 Million USD | -1.814% |
Smith & Nephew plc | 2.17 Billion USD | 99.355% |
STERIS plc | 3.12 Billion USD | 99.55% |
Stryker Corporation | 10.9 Billion USD | 99.871% |
Vapotherm, Inc. | 109.97 Million USD | 87.238% |
Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 99.712% |